Press release
Global Market Report Outlook 2025: Veterinary Active Pharmaceutical Ingredients Manufacturing Poised to Grow with CAGR of 7.9%
Veterinary Active Pharmaceutical Ingredients Manufacturing
What Is The Projected Market Size Of The Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2025 And Its Growth Rate?
• Market rose from $7.46 billion in 2024 to projected $8.05 billion in 2025, growing at CAGR of 7.9% due to rising pet ownership and increased R&D investments.
• Expected to reach $11.19 billion in 2029 with a CAGR of 8.6%, driven by advancements in personalized veterinary medicine, growing animal welfare importance, and increasing demand for nutraceuticals.
What Is Driving The Growth In The Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2025?
The surge in pet ownership directly fuels the Veterinary Active Pharmaceutical Ingredients manufacturing market growth. Pet owners, providing necessary health facilities for their pets, are increasing the demand for veterinary drugs. In 2022, according to Animal Medicines Australia, pet ownership witnessed a substantial rise in Australia, reaching 28,730.8 in 2022, up from only 39% in 2021. This 24% spike underscores the significant investment in pet care and adoption, underlining the popularity of pets in Australia's households.
Request A Free Sample Copy: https://www.thebusinessresearchcompany.com/sample.aspx?id=7942&type=smp
Who Are the Key Players Driving Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2025 Growth?
• Alivira Animal Health Limited
• Excel Industries Limited
• Ofichem Group B.V.
• Jiangsu Lingyun Pharmaceutical Co. Ltd.
• SUANFARMA S.A.
• NGL Fine-Chem Limited
• FIS - Fabbrica Italiana Sintetici S.p.A.
• Lupin Limited
• Aurobindo Pharma Limited
• Saneca Pharmaceuticals AS,
• Neuland Laboratories Limited
• Divi's Laboratories Limited
• Zoetis Inc.
• Grupo Indukern S.L.
• Sequent Scientific Limited
• Chempro Pharma Private Limited
• AMGIS Lifescience Ltd.
• Huvepharma AD
• Vetpharma Animal Health S.L.
• Qilu Pharma Spain S.A.
• INDUKERN Chemie AG
• Chemopharma S.A.
• Norbrook Laboratories Limited
• Ceva Santé Animale S.A.
• Vetoquinol S.A.
• Virbac S.A.
What Are The Key Trends In The Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2025?
• Technological advancements in manufacturing processes
• Increasing outsourcing of API manufacturing
• Shift toward biotechnology-based APIs
• Digitalization and automation in manufacturing
• Globalization of the veterinary API market
What Are The Segments Of The Global Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2025?
• By Product: Antiparasitic, Anti-Infectives, Vaccines, NSAIDs
• By Service Type: In House, Contract Outsourcing
• By Synthesis Type: Chemical Based API, Biological API, Highly Potent API
Which Region Leads The Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2025?
North America dominated the Veterinary Active Pharmaceutical Ingredients manufacturing market in 2024. The market report covers various regions, including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Pre-book the Report for Swift Delivery: https://www.thebusinessresearchcompany.com/report/veterinary-active-pharmaceutical-ingredients-manufacturing-global-market-report
What Is Covered In The Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2025 Global Market Report?
- Market Size Analysis: Analyze the Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2025 size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2025 for effective categorization.
- Key Player Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2025 growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2025.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report: https://www.thebusinessresearchcompany.com/Customise?id=7942&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Market Report Outlook 2025: Veterinary Active Pharmaceutical Ingredients Manufacturing Poised to Grow with CAGR of 7.9% here
News-ID: 3822505 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
